Thera-Zyme

Para S2 To S4

F
N+ Score46
Joint & BoneServing: 2 Capsule(s)Type: Other Combinations

Para S2 To S4 by Thera-Zyme is a joint and bone support supplement containing 5 ingredients. Key ingredients include 52mg of Calcium, 200mg of Fenugreek, 140mg of Horsetail, 70mg of Shiitake, and a 60mg Proprietary Plant Enzyme Blend. Research suggests Calcium is commonly used for bone health, but the 52mg provided is significantly underdosed compared to typical clinical recommendations. This product received an N+ Score of 46, earning an 'F' grade, indicating a below-average quality based on ingredient efficacy and dosing. It may be considered by individuals seeking a multi-ingredient blend for general joint and bone support, but potential users should note the low Calcium dosage. The product's overall formulation does not feature any clinically dosed ingredients.

About This Product

Para S2 To S4 by Thera-Zyme is a joint & bone supplement containing 5 active ingredients. It has earned an N+ Score of 46/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy0/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Several ingredients below clinically effective doses
  • Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Calcium52.000 mgUnder
Horsetail140.000 mgN/A
Fenugreek200.000 mgN/A
Shiitake70.000 mgN/A
Proprietary Plant Enzyme Blend60.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.